Thalidomide






1099 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 700507 On the application of thalidomide as a block of functional groups of proteins in histochemical investigations. Folia Histochem Cytochem (Krakow) 1978 1
2 1466907 Effect of blocking TNF-alpha on intracellular BCG (Bacillus Calmette Guerin) growth in human monocyte-derived macrophages. FEMS Microbiol Immunol 1992 Dec 1
3 1548069 Tumor necrosis factor production in patients with leprosy. Infect Immun 1992 Apr 1
4 1569817 Thalidomide's effectiveness in erythema nodosum leprosum is associated with a decrease in CD4+ cells in the peripheral blood. Lepr Rev 1992 Mar 4
5 1588290 Prolonged treatment with recombinant interferon gamma induces erythema nodosum leprosum in lepromatous leprosy patients. J Exp Med 1992 Jun 1 3
6 1997652 Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med 1991 Mar 1 3
7 2262716 Thalidomide in type-2 lepra reaction--a clinical experience. Indian J Lepr 1990 Jul-Sep 1
8 2397633 Behçet's disease, palmoplantar pustulosis and HLA-B27 treatment with thalidomide. Clin Exp Rheumatol 1990 Jul-Aug 1
9 3970671 Efficacy of pharmacologic glucagon in acute experimental pancreatitis. Arch Surg 1985 Mar 1
10 5300279 [Thalidomide: effect on serum ceruloplasmin]. Hospital (Rio J) 1966 Sep 1
11 5593734 [Malformation and liver damage. On the necessary 2nd noxa in experimental thalidomide embryopathies]. Wien Med Wochenschr 1967 Apr 15 1
12 6548496 Thalidomide in lepra reaction (ENL) in lepromatous leprosy patients. Indian J Lepr 1984 Apr-Jun 2
13 7516993 Thalidomide and the immune system. 3. Simultaneous up- and down-regulation of different integrin receptors on human white blood cells. Life Sci 1994 5
14 7558825 [Successful treatment of a case of cutaneous Langerhans cell granulomatosis with 2-chlorodeoxyadenosine and thalidomide]. Hautarzt 1995 Aug 1
15 7561198 Thalidomide inhibits tumor necrosis factor-alpha production by lipopolysaccharide- and lipoarabinomannan-stimulated human microglial cells. J Infect Dis 1995 Oct 4
16 7590113 Exacerbation of acetaminophen hepatotoxicity by thalidomide and protection by nicotinic acid amide. Gen Pharmacol 1995 Oct 5
17 7593465 Isotype-specific regulation of MHC class II gene expression in human monocytes by exogenous and endogenous tumor necrosis factor. J Clin Immunol 1995 Jul 1
18 7635184 Does thalidomide affect IL-2 response and production? Exp Hematol 1995 Aug 7
19 7640215 Effect of thalidomide on tumour necrosis factor production and anti-tumour activity induced by 5,6-dimethylxanthenone-4-acetic acid. Br J Cancer 1995 Aug 3
20 7713571 Cytokine regulation of disease progression in leprosy and tuberculosis. Immunobiology 1994 Oct 3
21 7742424 Thalidomide as treatment of refractory aphthous ulceration related to human immunodeficiency virus infection. Clin Infect Dis 1995 Feb 1
22 7830502 Thalidomide and the immune system. 4. Down-regulation of the CD26 receptor, probably involved in the binding of HIV components to T cells in primates. Life Sci 1995 4
23 7844376 Pharmacologic inhibitors of tumor necrosis factor production exert differential effects in lethal endotoxemia and in infection with live microorganisms in mice. J Infect Dis 1995 Feb 1
24 7851006 The immunosuppressive drug thalidomide induces T helper cell type 2 (Th2) and concomitantly inhibits Th1 cytokine production in mitogen- and antigen-stimulated human peripheral blood mononuclear cell cultures. Clin Exp Immunol 1995 Feb 9
25 7895307 N-Alkylphthalimides: structural requirement of thalidomidal action on 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor alpha production by human leukemia HL-60 cells. Chem Pharm Bull (Tokyo) 1995 Jan 1
26 8069968 (S)-form of alpha-methyl-N(alpha)-phthalimidoglutarimide, but not its (R)-form, enhanced phorbol ester-induced tumor necrosis factor-alpha production by human leukemia cell HL-60: implication of optical resolution of thalidomidal effects. Chem Pharm Bull (Tokyo) 1994 May 3
27 8090535 Autoimmunity in human immunodeficiency virus infection and the use of thalidomide. Panminerva Med 1994 Mar 1
28 8135786 Enhancement of phorbol ester-induced production of tumor necrosis factor alpha by thalidomide. Biochem Biophys Res Commun 1994 Mar 15 4
29 8177242 Inhibition of tumor necrosis factor-alpha by thalidomide in magnesium deficiency. Mol Cell Biochem 1993 Dec 22 2
30 8327469 Thalidomide inhibits the replication of human immunodeficiency virus type 1. Proc Natl Acad Sci U S A 1993 Jul 1 4
31 8335978 The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum. J Infect Dis 1993 Aug 3
32 8433015 Recent advances in cytokine therapy in leprosy. J Infect Dis 1993 Mar 1
33 8452474 Thalidomide derivatives and the immune system. I. Changes in the pattern of integrin receptors and other surface markers on T lymphocyte subpopulations of marmoset blood. Arch Toxicol 1993 2
34 8496685 Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation. J Exp Med 1993 Jun 1 6
35 8521296 Thalidomide treatment reduces tumor necrosis factor alpha production and enhances weight gain in patients with pulmonary tuberculosis. Mol Med 1995 May 8
36 8527011 Thalidomide: rationale for renewed use in immunological disorders. Drug Saf 1995 Jun 1
37 8538367 Down-regulation of adhesion receptors on cells of primate embryos as a probable mechanism of the teratogenic action of thalidomide. Life Sci 1996 1
38 8603261 The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infection. J Acquir Immune Defic Syndr Hum Retrovirol 1996 Mar 1 3
39 8627072 Multinucleated giant cell formation of swine microglia induced by Mycobacterium bovis. J Infect Dis 1996 May 2
40 8634679 The effect of thalidomide on BCG-induced granulomas in mice. Braz J Med Biol Res 1995 Oct 3
41 8655287 Thalidomide increases the synthesis of IL-2 in cultures of human mononuclear cells stimulated with Concanavalin-A, Staphylococcal enterotoxin A, and purified protein derivative. Immunopharmacology 1995 Nov 9
42 8661187 Thalidomide inhibits TNF response and increases survival following endotoxin injection in rats. J Surg Res 1996 Jun 5
43 8675185 Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats. Hepatology 1996 Jun 3
44 8683039 Thalidomide can be either agonistic or antagonistic to LPS evoked synthesis of TNF-alpha by mononuclear cells. Immunopharmacol Immunotoxicol 1996 Feb 6
45 8702405 Inducer-specific bidirectional regulation by thalidomide and phenylphthalimides of tumor necrosis factor-alpha production. Biochem Biophys Res Commun 1996 Jul 16 4
46 8728022 Synergistic effects of thalidomide and poly (ADP-ribose) polymerase inhibition on type II collagen-induced arthritis in mice. Inflammation 1996 Apr 1
47 8745000 Effects of thalidomide on the local Shwartzman reaction in mice and rabbits. FEMS Immunol Med Microbiol 1995 Dec 2
48 8755512 Binding of thalidomide to alpha1-acid glycoprotein may be involved in its inhibition of tumor necrosis factor alpha production. Proc Natl Acad Sci U S A 1996 Jul 23 3
49 8806653 Cell type-/inducer-specific bidirectional regulation by thalidomide and phenylphthalimides of tumor necrosis factor-alpha production and its enantio-dependence. Biochem Biophys Res Commun 1996 Sep 13 1
50 8825912 Effect of thalidomide on the inflammatory response in cerebrospinal fluid in experimental bacterial meningitis. Microb Pathog 1995 Oct 4